Skip to main content
. 2010 Mar;3(1):26–36. doi: 10.1111/j.1753-5174.2009.00028.x

Figure 2.

Figure 2

Percentage of participants in the intent-to-treat population with (A) HIV-1 RNA <50 copies/mL and (B) HIV-1 RNA <400 copies/mL at baseline and at week 24 overall and by subpopulation. HCV = hepatitis C virus; PI = protease inhibitor.